MYGN
MYGN
US62855J1043
Myriad Genetics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
412.25M EUR
545.88M EUR
424.8M EUR
575.03M EUR
Enterprise Value
497.03M EUR
545.88M EUR
511.9M EUR
635.23M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-7.31x
--
--
--
Price to Sales
0.51x
0.89x
0.51x
0.7x
Price to Book
1.36x
--
1.26x
1.56x
EV/Revenue
0.62x
0.89x
0.62x
0.77x
EV/EBITDA
-12.33x
--
--
--
Price to FCF (P/FCF)
22.67x
--
--
--
EV/FCF
27.33x
--
--
--
FCF Yield
4.41%
-0.49%
-5.46%
-4.45%
ende